OLPX
$1.24-0.01 (-1.20%)
Olaplex Holdings, Inc., through its subsidiaries, develops, manufactures, and sells haircare products in the United States and internationally.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Olaplex Holdings, Inc., through its subsidiaries, develops, manufactures, and sells haircare products in the United States and internationally. The company offers hair care shampoos and conditioners for use in treatment, maintenance, and protection o...
Recent News
The Top 5 Analyst Questions From Olaplex’s Q4 Earnings Call
Olaplex’s fourth quarter was marked by year-on-year revenue growth, driven primarily by improved sell-through in the professional and direct-to-consumer channels and a refreshed brand identity. However, the market responded negatively to the results, reflecting investor concerns about the company’s declining operating margin and the lingering effects of recent channel realignment. CEO Amanda Baldwin highlighted a "comprehensive new visual identity supported by a 360-degree marketing engine" and
3 Profitable Stocks Walking a Fine Line
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Olaplex (OLPX) Q4 2025 Revenue Grows 4% to $105.1M Despite EPS Miss
Olaplex Holdings Inc. (NASDAQ:OLPX) is one of the best new penny stocks to buy. On March 5, Olaplex Holdings reported its Q4 2025 financial results, beating earnings expectations with an adjusted EPS of $0.01. The company stabilized its net sales for the full-year 2025 at $423 million, ending a period of declines in previous years. […]
Olaplex Relaunches Brand As Market Weighs Turnaround And Valuation Gap
Olaplex Holdings (NasdaqGS:OLPX) is rolling out a brand relaunch centered on new products and refreshed messaging. The company introduced No.3PLUS Complete Repair Treatment as a new flagship addition to its repair franchise. Olaplex agreed to acquire Purvala Bioscience to add bio inspired technologies and deepen its research capabilities. Olaplex is pushing this reset while its share price sits at $1.345 and the stock shows steep multi year declines, with a 66.3% drop over 3 years and a...
Olaplex (OLPX) Is Down 16.5% After Softer 2026 Outlook and Q4 Loss - What's Changed
In early March 2026, Olaplex Holdings reported fourth-quarter 2025 sales of US$105.12 million with a net loss of US$13.1 million, and issued 2026 net sales guidance of US$414 million to US$435 million alongside an employee share offering and a new No.3PLUS product launch. The combination of flat full-year 2025 sales, a swing from profit to loss, and management’s expectation of back-half-weighted 2026 demand underpins concerns about near-term profitability and execution of its transformation...